Article Information
History
- September 4, 2018.
Article Versions
- Version 1 (September 4, 2018 - 12:09).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joanna R. Thomas1,#,
- Kate M. Moore2,#,
- Caroline Sproat2,
- Horacio J. Maldonado-Lorca1,
- Stephanie Mo1,
- Syed Haider3,
- Dean Hammond1,
- Gareth J. Thomas5,
- Ian A. Prior1,
- Pedro R. Cutillas2,
- Louise J. Jones2,
- John F. Marshall2,† and
- Mark R. Morgan1,†
- 1Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool, L69 3BX, UK
- 2Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
- 3The Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, UK
- 4Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventative Medicine, Queen Mary University London, Charterhouse Square, London EC1M 6BQ, UK
- 5Cancer Sciences Division, Somers Building, Southampton General Hospital, Southampton, SO16 6YA, UK
- ↵†Corresponding author: Dr Mark R. Morgan, PhD, Cellular & Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool, L69 3BX, UK. Tel: [+44](0)151-795-4992 / e-mail: mark.morgan{at}liverpool.ac.uk / Twitter:@M_MorganLab Professor John F. Marshall, PhD, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK Tel: [+44](0) 20 7882 3580 / e-mail: j.f.marshall{at}qmul.ac.uk
↵# Denotes equal contribution